Cost concerns of patients with cancer

Journal of Oncology Practice

Volumn 9, Issue 5, 2013, Pages 251-257

  Stump, Tammy K ^b   Eghan, Naa ^b   Egleston, Brian L ^b   Hamilton, Olivia ^b   Pirollo, Melanie ^b   Schwartz, J Sanford ^b   Armstrong, Katrina ^b   Beck, J Robert ^b   Meropol, Neal J ^b   Wong, Yu Ning ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; CONTROLLED STUDY; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEALTH CARE COST; HEALTH INSURANCE; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; OPEN ENDED QUESTIONNAIRE; OPTIMISM; PATIENT CARE; PROSTATE CANCER; SKIN CANCER; STRUCTURED QUESTIONNAIRE; UROGENITAL TRACT CANCER; VERY ELDERLY; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH EXPENDITURES; HOSPITALS, COMMUNITY; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES;

EID: 84892595184     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.000929     Document Type: Article

References (17)

1. Meropol NJ, Schulman KA: Cost of cancer care: Issues and implications. J Clin Oncol 25: 180-186, 2007 (Pubitemid 350003031)
2. Schrag D, Hanger M: Medical oncologists' views on communicating with patients about chemotherapy costs: A pilot survey. J Clin Oncol 25: 233-237, 2007 (Pubitemid 350003040)
3. Baile WF, Buckman R, Lenzi R, et al: SPIKES - A six-step protocol for delivering bad news: Application to the patient with cancer. Oncologist 5: 302-311, 2000 (Pubitemid 30666477)
4. McFarlane J, Riggins J, Smith TJ: SPIKE$: A six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol 26: 4200-4204, 2008
5. Wagner L, Lacey MD: The hidden costs of cancer care: An overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs 8:279- 287, 2004
6. Shankaran V, Jolly S, Blough D, et al: Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol 30: 1608-1614, 2012
7. Wood S, Hanoch Y, Barnes A, et al: Numeracy and Medicare Part D: The importance of choice and literacy for numbers in optimizing decision making for Medicare's prescription drug program. Psychol Aging 26: 295-307, 2011
8. Schou I, Ekeberg Ø, Ruland CM: The mediating role of appraisal and coping in the relationship between optimism-pessimism and quality of life. Psycho-oncology 14: 718-727, 2005 (Pubitemid 41320785)
9. Wong YN, Egleston BL, Sachdeva K, et al: Cancer patients' trade-offs among efficacy, toxicity and out-of pocket cost in the curative and non-curative setting. Med Care (in press)
10. Zikmund-Fisher BJ, Smith DM, Ubel PA, et al: Validation of the Subjective Numeracy Scale: Effects of low numeracy on comprehension of risk communications and utility elicitations. Med Decis Making 27: 663-671, 2007 (Pubitemid 47547593)
11. Fagerlin A, Zikmund-Fisher BJ, Ubel PA, et al: Measuring numeracy without a math test: Development of the Subjective Numeracy Scale. Med Decis Making 27: 572-580, 2007
12. Scheier MF, Carver CS: Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. Health Psychol 4: 219-247, 1985
13. Hosmer D, Lemeshow S: Applied Logistic Regression. New York, NY, Wiley, 2000
14. Hsu J, Price M, Huang J, et al: Unintended consequences of caps on Medicare drug benefits. N Engl J Med 354: 2349-2359, 2006 (Pubitemid 43801280)
15. Markman M, Luce R: Impact of the cost of cancer treatment: An Internetbased survey. J Oncol Pract 6: 69-73, 2010
16. Gurmankin AD, Baron J, Armstrong K: Intended message versus message received in hypothetical physician risk communications: Exploring the gap. Risk Anal 24: 1337-1347, 2004 (Pubitemid 39532463)
17. Milbury K, Tannir NM, Cohen L: Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinoma. Ann Behav Med 42: 313-320, 2011